Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose sevoflurane plus TIVA effects on MEPs in infants
jRCT1041230094Not yet recruiting
- Start
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of sevoflurane in Back disorder (2 arms). Primary endpoint: Attenuation of upper extremity MEP amplitude. Planned start Oct 2023; status: not yet recruiting.
02
Drugs
sevoflurane
03
Conditions
Back disorder
Beyond the preview
Go deeper on jRCT1041230094.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1041230094.